# Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2

> **NCT00573391** · PHASE3 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 5 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade, Thalidomide, and Dexamethasone
- **DRUG:** Velcade, Melphalan, and Dexamethasone

## Key facts

- **NCT ID:** NCT00573391
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2011-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573391, "Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00573391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*